0001140361-24-021818.txt : 20240424 0001140361-24-021818.hdr.sgml : 20240424 20240424211202 ACCESSION NUMBER: 0001140361-24-021818 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240422 FILED AS OF DATE: 20240424 DATE AS OF CHANGE: 20240424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kumar Rakhi CENTRAL INDEX KEY: 0001856296 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 24872513 MAIL ADDRESS: STREET 1: C/O NEUROPACE INC STREET 2: 455 N BERNARDO AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 4 1 form4.xml FORM 4 X0508 4 2024-04-22 0001635088 Roivant Sciences Ltd. ROIV 0001856296 Kumar Rakhi C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true Chief Accounting Officer false Common Shares 2024-04-22 4 A 0 38685 0 D 216573 D Stock Option (Right to Buy) 10.6 2024-04-22 4 A 0 230548 0 A 2034-04-21 Common Shares 230548 230548 D Reflects an award of 38,685 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2024. 1/4 of the RSUs service-vest on the date thirteen (13) months from the vesting commencement date; and the balance of the RSUs service-vest in series of twelve (12) successive equal quarterly installments measured from the date thirteen (13) months from the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date. Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date. By: /s/ Jo Chen, as Attorney-in-Fact for Rakhi Kumar 2024-04-24